-
Mashup Score: 0Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients - 5 day(s) ago
While new cardiac research is published every day, some clinical trials make a more significant impact than others. The SMART (SMall Annuli Randomized To EvolutTM or SAPIENTM*) trial¹, for example, explored differences between patients with a small aortic annulus who were treated with supra-annular, self-expanding EvolutTM valves from Medtronic and those treated with intra-annular, balloon-expandable SAPIEN 3TM valves from Edwards Lifesciences.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
The so-called “weekend effect” seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
The so-called “weekend effect” seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Valve durability after TAVR: Cardiologists track how deterioration influences outcomes - 25 day(s) ago
Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards - 26 day(s) ago
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
RBBB remains the single strongest predictor for PPMI after TAVR, but high AV calcium scores still provide care teams with considerable value.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD - 2 month(s) ago
Percutaneous treatment was linked to improved survival and fewer adverse events than surgery when patients presented with both symptomatic severe aortic stenosis and complex coronary artery disease.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Years of progress have made TAVR more effective when treating concomitant mitral stenosis - 2 month(s) ago
Newer balloon-expandable TAVR valves are associated with much better outcomes for patients presenting with both severe AS and severe MS than older models.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
Physicians are leaning into supra-annular, self-expanding #TAVR valves for women and small-annulus patients #cardiology @MDT_StructHeart @Medtronic https://t.co/albDEUH4sP